Literature DB >> 1825102

Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release.

C Arzubiaga1, J Morrow, L J Roberts, I Biaggioni.   

Abstract

Recent evidence suggests that neural transmitters, including neuropeptides, may modulate the release of mast cell mediators. Because neuropeptide Y (NPY) has recently been recognized as a putative cotransmitter in noradrenergic neurons, we studied the effect of NPY on purified rat peritoneal mast cells. NPY induced mast cell degranulation, as assessed by a dose-dependent increase in net release of beta-hexosaminidase. The concentration that produced 50% of the maximal effect, approximately 10 mumol/L, evoked a 40% +/- 3% release. As previously reported for other neuropeptides, release was fast with maximal release already achieved at 60 seconds. Release was at 4 degrees C. In contrast to its effects on mast cell degranulation, NPY had no effect on the generation of prostaglandin D2, the major mast cell cyclooxygenase product. By comparison, the calcium ionophore A23187, at doses (4 mumol/L) that evoked comparable release of beta-hexosaminidase, stimulated a net release of 37 +/- 9 ng of PGD2 per 10(6) mast cells. These results raise the possibility that NPY may act as a modulator between the autonomic nervous system and mast cells. The results also imply that with neuropeptide stimulation, the release of preformed and newly formed mast cell mediators are mediated through independent pathways.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825102     DOI: 10.1016/0091-6749(91)90216-b

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

Review 1.  Interactions of mast cells with the nervous system--recent advances.

Authors:  D Johnson; W Krenger
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

Review 2.  Potential targets for intervention in radiation-induced heart disease.

Authors:  M Boerma; M Hauer-Jensen
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

Review 3.  Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

Authors:  Cristina Stasi; Massimo Rosselli; Massimo Bellini; Giacomo Laffi; Stefano Milani
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

4.  Mast cells: a unique source of renin.

Authors:  Randi B Silver; Alicia C Reid; Christina J Mackins; Trevor Askwith; Ulrich Schaefer; Doris Herzlinger; Roberto Levi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

5.  Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells.

Authors:  Sergey Ryzhov; Rinat Zaynagetdinov; Anna E Goldstein; Sergey V Novitskiy; Mikhail M Dikov; Michael R Blackburn; Italo Biaggioni; Igor Feoktistov
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

6.  Preclinical research into basic mechanisms of radiation-induced heart disease.

Authors:  M Boerma; M Hauer-Jensen
Journal:  Cardiol Res Pract       Date:  2010-10-04       Impact factor: 1.866

7.  The Postural Tachycardia Syndrome (POTS): pathophysiology, diagnosis & management.

Authors:  Satish R Raj
Journal:  Indian Pacing Electrophysiol J       Date:  2006-04-01

8.  Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study.

Authors:  Cristina Stasi; Massimo Bellini; Dario Gambaccini; Emiliano Duranti; Nicola de Bortoli; Bernardo Fani; Eleonora Albano; Salvatore Russo; Isabella Sudano; Giacomo Laffi; Stefano Taddei; Santino Marchi; Rosa Maria Bruno
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.